Objective
The University Group Diabetes Program (UGDP) study showed sulfonylureas may bring more harm than benefit to diabetic patients. Since then there has been no strong evidence proving sulfonylureas can prevent mortality or major cardiovascular clinical events. But sulfonylureas are still widely used in diabetes treatment. ORIGIN study has shown that insulin treatment which was considered as the most effective and natural remedy of diabetes for many years, had no beneficial effect on mortality and complications of diabetes. Is it reasonable to treat a disease with hyperinsulinemia and insulin resistance with insulin or insulin secretagogues. In this study we aimed to evaluate the type 2 diabetes treatment perception of doctors practicing in internal medicine.
Method
A survey about type 2 diabetes treatment and relevant complications were conducted on 29 doctors practicing internal medicine. A questionnaire about their choices in treatment of type 2 diabetes and how much they have faith in those drugs was filled by participants.